- Home
- RLMD vs BGI Comparison
RLMD vs BGI Comparison
Compare RLMD & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- BGI
- Stock Information
- Founded
- RLMD 2004
- BGI 1879
- Country
- RLMD United States
- BGI Canada
- Employees
- RLMD N/A
- BGI N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- RLMD Health Care
- BGI
- Exchange
- RLMD Nasdaq
- BGI Nasdaq
- Market Cap
- RLMD 20.3M
- BGI 17.8M
- IPO Year
- RLMD N/A
- BGI 2005
- Fundamental
- Price
- RLMD $0.64
- BGI $0.77
- Analyst Decision
- RLMD Buy
- BGI
- Analyst Count
- RLMD 3
- BGI 0
- Target Price
- RLMD $5.00
- BGI N/A
- AVG Volume (30 Days)
- RLMD 211.8K
- BGI 81.3K
- Earning Date
- RLMD 08-11-2025
- BGI 07-25-2025
- Dividend Yield
- RLMD N/A
- BGI N/A
- EPS Growth
- RLMD N/A
- BGI N/A
- EPS
- RLMD N/A
- BGI N/A
- Revenue
- RLMD N/A
- BGI $124,446,731.00
- Revenue This Year
- RLMD N/A
- BGI N/A
- Revenue Next Year
- RLMD N/A
- BGI N/A
- P/E Ratio
- RLMD N/A
- BGI N/A
- Revenue Growth
- RLMD N/A
- BGI N/A
- 52 Week Low
- RLMD $0.24
- BGI $0.74
- 52 Week High
- RLMD $4.02
- BGI $2.95
- Technical
- Relative Strength Index (RSI)
- RLMD 50.91
- BGI 32.32
- Support Level
- RLMD $0.60
- BGI $0.82
- Resistance Level
- RLMD $0.74
- BGI $0.96
- Average True Range (ATR)
- RLMD 0.06
- BGI 0.08
- MACD
- RLMD 0.00
- BGI -0.01
- Stochastic Oscillator
- RLMD 44.19
- BGI 13.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.